ENTITY
Jinxin Fertility

Jinxin Fertility (1951 HK)

126
Analysis
Health Care • China
Jinxin Fertility Group is a leading international provider of assisted reproductive services (ARS) and assisted reproductive technology (ART). Its core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), egg retrieval, embryo transfer, and genetic screening, alongside a range of women's health services. The company is headquartered in Chengdu, China, and was founded in 1951.
more
•04 Jan 2021 20:50

Jinxin Fertility (锦欣生殖) Placement - Only Warburg Selling This Time

Amethyst Gem (Warburg Pincus) is looking to sell 80m shares in Jinxin Fertility Co Ltd (1951 HK).  Post selldown, Amethyst Gem will still have...

Share
•07 Jul 2020 20:22

Jinxin Fertility Placement: Sound Fundamentals

3 shareholders of Jinxin Fertility come to market to sell 207.6 million shares. In this note, we will provide our thoughts on the deal. We like the...

Logo
593 Views
Share
•26 Jun 2020 13:28

Hygeia Healthcare (海吉亚) IPO Trading: Upside Might Take Time to Crystalize

Hygeia Healthcare raised HKD 2,072 million (USD 267 m) from its global offering and will list on the Hong Kong Stock Exchange next Monday. In our...

Logo
519 Views
Share
•16 Jun 2020 11:37

Hygeia Healthcare (海吉亚) IPO: Hot Deal but Expect Tiny Allocation

Hygeia Healthcare Group, a leading oncology specialized healthcare group, started book building to raise up to USD 286 million Hong Kong...

Logo
556 Views
Share
•10 Jun 2020 10:21

Hygeia Healthcare (海吉亚) Pre-IPO: PHIP Updates and Thoughts on Valuation

Hygeia Healthcare Group, a leading oncology specialized healthcare group, started pre-marketing its USD 300 million Hong Kong listing. The company...

Logo
600 Views
Share
x